Coming December: ASH publishes its late-breaking abstracts. We’ll add the organizations presenting them.

Ascentage Pharma at ASH 2026

Dec 12–15, 2026 New Orleans, LA ~30k attendees Website

Ascentage Pharma brings 1 presentation to ASH 2026 in New Orleans, and exhibits at Booth 1957. Its research centres on lymphoma drug combinations in preclinical models. It covers an EED inhibitor that works alongside the BCL-2 inhibitor lisaftoclax.

OrganizationASH 2026 Attendance
Ascentage Pharma
Suzhou, China
Biotech
Biopharmaceutical company developing hematology drugs including olverembatinib, a third-generation TKI, and lisaftoclax, a Bcl-2 inhibitor.
Booth
Exhibiting at Booth 1957
Sat, Dec 1211:00am–5:00pmSun, Dec 1310:00am–5:00pmMon, Dec 1410:00am–2:00pm

Explore the full ASH 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in New Orleans. Leave your work email and we’ll be in touch.

Privacy

Download the full ASH 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Ascentage Pharma

Tell us what you sell and we’ll find the people at Ascentage Pharma most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction